|
| Familial cold autoinflammatory syndrome | Muckle-Wells syndrome | Neonatal onset multisystem inflammatory disorder
| NLRP12-associated autoinflammatory disorder (or familial cold autoinflammatory syndrome 2) |
|
Gene | NLRP3 (1q44) | NLRP12 (19q13.42) |
Inheritance | Autosomal dominant |
Protein encoded | Cryopyrin | Monarch 1 |
OMIM | 120100 | 191900 | 607115 | 609648 |
Onset age | Infancy | Infancy-adolescence | Prenatal period | Infancy |
Duration of clinical signs | Less than 24 hours | Subcontinuous | Continuous | Periodic |
Fever | Short duration | Recurrent | Recurrent | Periodic |
Rash features | Cold-induced, urticaria-like | Cold-induced, urticaria-like, and evanescent | Migratory, polymorphous, and urticaria-like | Cold-induced, urticaria-like |
Ocular signs | Conjunctivitis | Conjunctivitis | Chronic papilledema, optic nerve atrophy, and visual loss | — |
Muscular-skeletal symptoms | Arthralgia, transient joint stiffness | Lifelong arthralgias, nonerosive arthritides, and chronic fatigue | Deforming osteoarthropathy of large joints (with abnormal ossification of patellae) | Arthralgia |
Neurologic signs | — | Risk of sensorineural deafness | Chronic aseptic meningitis, sensorineural deafness | Headache, sensorineural deafness |
Major complication | Amyloidosis of AA type |
Treatment | Interleukin-1 antagonists (canakinumab) | Interleukin-1 antagonists |
|